Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImpact Health Regulatory News (IHR)

  • There is currently no data for IHR

Director Shareholding

16 Mar 2022 11:04

RNS Number : 9782E
Impact Healthcare REIT PLC
16 March 2022
 

16 March 2022

Impact Healthcare REIT plc

("Impact" or the "Company" or, together with its subsidiaries, the "Group")

PDMR Notification

The Company announces that Chris Santer, Non-Executive Director of the Company and a person discharging managerial responsibilities in the Company ("PDMR"), on 21 February 2022, was allotted 1,570 ordinary shares at a price of 114 pence per share. This allotment took place under the Company's Open Offer, Initial Placing, Offer for Subscription and Intermediaries Offer announced on 27 January 2022.

In total Chris Santer will be interested in 14,137 Ordinary Shares, representing approximately 0.0037% per cent of the Company's issued Ordinary Share capital.

PDMR Notification Form:

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further details:

1.

Details of the person discharging managerial responsibilities ("PDMR") / person closely associated ("PCA")

a)

Name

Christopher John Santer

2.

Reason for the Notification

a)

Position/status

PDMRNon-Executive Director

b)

Initial notification/amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Impact Healthcare REIT PLC

b)

LEI

213800AX3FHPMJL4IJ53

4.

Details of the transaction(s):section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares of 1 pence each

Identification code

GB00BYXVMJ03

b)

Nature of the Transaction

Acquisition of Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

114 pence

1,570

 

d)

Aggregated informationAggregated volume Price

1,570 ordinary shares in aggregate£1,789.80 

e)

Date of the transaction

21 February 2022

f)

Place of the transaction

London Stock Exchange

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 

ENDS

JTC (UK) Limited - Company Secretary

Christopher Gibbons

 

+44 (0) 203 846 9774

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGPUGUWUPPGGQ
Date   Source Headline
10th Jun 20197:00 amRNSAcquisitions
7th Jun 20197:00 amRNSEPRA INDEX INCLUSION
31st May 20197:00 amRNSTotal Voting Rights
17th May 20197:00 amRNSHolding(s) in Company
16th May 20191:42 pmRNSHolding(s) in Company
16th May 201911:29 amRNSHolding(s) in Company
15th May 20193:00 pmRNSDirector/PDMR Shareholding
15th May 201911:39 amRNSResult of AGM
10th May 20199:10 amRNSDirector Declaration
10th May 20197:00 amRNSResults of Issue
2nd May 20197:00 amRNSAcquisition
1st May 20197:00 amRNSNAV, Dividend Declaration & Trading Update
24th Apr 20199:41 amRNSHolding(s) in Company
23rd Apr 20199:43 amRNSPublication of Supplementary Prospectus
15th Apr 20197:00 amRNSPROPOSED PLACING OF ORDINARY SHARES
12th Apr 20197:00 amRNSAnnual Report & Accounts and Notice of AGM
28th Mar 20197:00 amRNSFull year results
26th Mar 20195:12 pmRNSNotice of Full year Results
18th Mar 20195:20 pmRNSHolding(s) in Company
15th Mar 20197:00 amRNSInvestment Adviser Appointed as AIFM
13th Mar 20194:35 pmRNSPublication of Supplementary Prospectus
7th Mar 20197:00 amRNSNew Loan Facility
5th Mar 20192:57 pmRNSResult of Meeting
1st Mar 20197:00 amRNSAppointment of Non-Executive Director
28th Feb 20199:33 amRNSHolding(s) in Company
11th Feb 20192:44 pmRNSPublication of a Prospectus
7th Feb 20193:37 pmRNSHolding(s) in Company
5th Feb 20197:00 amRNSPLACING PROGRAMME AND MIGRATION TO PREMIUM SEGMENT
30th Jan 20197:00 amRNSNAV, Dividend Declaration & Trading Update
29th Jan 20196:15 pmRNSHolding(s) in Company
7th Jan 20195:07 pmRNSHolding(s) in Company
30th Nov 20187:00 amRNSUPDATE ON PIPELINE ACQUISITIONS AND FUNDRAISING
13th Nov 20185:33 pmRNSMajor Holding(s) in Company
6th Nov 20187:00 amRNSAcquisition
2nd Nov 20187:00 amRNSAcquisition
24th Oct 20187:00 amRNSPipeline Acquisitions and Possible Fundraising
23rd Oct 20187:00 amRNSNAV, Dividend Declaration and Trading Update
21st Sep 20187:00 amRNSAcquisition
20th Aug 20187:00 amRNSKey Information Document ("KID")
9th Aug 20187:01 amRNSInterim Results for the period to 30 June 2018
9th Aug 20187:00 amRNSDividend Declaration
8th Aug 20187:00 amRNSNOTICE OF HALF YEAR RESULTS
6th Aug 20187:00 amRNSACQUISITIONS UPDATE
2nd Aug 20185:09 pmRNSHolding(s) in Company
25th Jul 20184:06 pmRNSHolding(s) in Company
18th Jul 20182:07 pmRNSDavid Brooks, Non-Executive Director
18th Jun 20187:00 amRNSNew Loan Facility
23rd May 20187:00 amRNSAcquisition
1st May 20189:23 amRNSHolding(s) in Company
30th Apr 20183:32 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.